BRWD1P3

Across TCGA pan-cancer cohorts, BRWD1P3 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated BRWD1P3 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher BRWD1P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BRWD1P3 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

SKCM, UCEC, and LGG are the cancer types where BRWD1P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.435	0.740	<.001	60	view →
UCEC	OS	Tertile	All	0.779	0.881	.007	48	view →
LGG	OS	Tertile	All	0.665	0.894	<.001	27	view →
THCA	DFS	Tertile	IV	0.637	0.964	.011	24	view →
KIRC	OS	Tertile	All	0.455	0.653	.002	24	view →
HNSC	DFS	Tertile	IV	0.360	0.560	.018	24	view →
ACC	OS	Tertile	III,IV	0.189	0.757	<.001	18	view →
GBM	OS	Tertile	All	0.109	0.415	.032	9	view →
BLCA	OS	Quartile	All	0.537	0.381	.025	8	view →
PRAD	OS	Tertile	All	0.946	0.996	.034	6	view →
STAD	DFS	Quartile	IV	0.102	0.416	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

BRWD1P3–SKCM (DFS)

Open the SKCM breakdown →